The increased risk of various types of carcinomas, including non-melanoma skin carcinoma, in patients with NF1 is recognized, however, the molecular mechanism of carcinoma development in patients with NF1 is not well understood. This evidence concerns the gene NF1 and non-melanoma skin carcinoma.